These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4287128)

  • 21. [Study of antibodies neutralizing poliomyelitis viruses in Greece].
    Pavlatou M; Triantaphylli I; Katsilambrou-Varonou E
    Ann Inst Pasteur (Paris); 1965 Apr; 108(4):451-60. PubMed ID: 4283972
    [No Abstract]   [Full Text] [Related]  

  • 22. [Surveillance of levels of neutralizing antibodies against poliovirus among children aged 0-3 in rural areas of Anhui Province].
    Shen Y; Zhao Y; Liu D
    Zhonghua Yu Fang Yi Xue Za Zhi; 1995 Nov; 29(6):335-8. PubMed ID: 8697935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neutralizing antibody titer against Japanese encephalitis virus in healthy adults living in Kumamoto prefecture].
    Yamada A; Goto I; Ishida H; Ueno N
    Nihon Densenbyo Gakkai Zasshi; 1967 Oct; 41(7):252-5. PubMed ID: 4298132
    [No Abstract]   [Full Text] [Related]  

  • 24. A seroprevalence study of poliovirus antibody in the population of northern Greece.
    Frantzidou F; Diza E; Halkia D; Antoniadis A
    Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to echovirus type 30 in the Canadian population.
    Duncan IB
    Can Med Assoc J; 1968 Oct; 99(16):786-90. PubMed ID: 4176074
    [No Abstract]   [Full Text] [Related]  

  • 26. The age distribution of neutralizing antibodies against varicella-zoster virus in healthy individuals.
    Ozaki T; Nagai H; Kimura T; Ichikawa T; Suzuki S; Kito H; Asano Y
    Biken J; 1980 Mar; 23(1):9-14. PubMed ID: 6254500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda.
    Mugisha L; Pauli G; Opuda-Asibo J; Joseph OO; Leendertz FH; Diedrich S
    J Med Primatol; 2010 Apr; 39(2):123-8. PubMed ID: 20102460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunity to poliovirus among children and the elderly in north-east Italy.
    Majori S; Baldo V; Poli A; Riolfatti M; Alborino F; Bonello C; Frau S; Baldovin T; Dal Zotto A; Romano G; Trivello R
    J Prev Med Hyg; 2006 Mar; 47(1):12-5. PubMed ID: 17061405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on serological response of attenuated live poliovirus vaccine. 1. On neutralizing antibodies affected by various dosage methods].
    Kami Y
    Kumamoto Igakkai Zasshi; 1966 Aug; 40(8):881-97. PubMed ID: 5953627
    [No Abstract]   [Full Text] [Related]  

  • 31. Poliovirus antibody status after vaccination with trivalent oral vaccine.
    Clara R; Deprettere A; van der Berghe D; Pattyn S
    Acta Paediatr Belg; 1976; 29(4):245-51. PubMed ID: 192040
    [No Abstract]   [Full Text] [Related]  

  • 32. Immune status of the population to poliovirus infection in Singapore.
    Goh KT; Yamazaki S
    Bull World Health Organ; 1987; 65(1):83-6. PubMed ID: 3034442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
    Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural Japanese encephalitis virus infection among humans in west and east Japan shows the need to continue a vaccination program.
    Konishi E; Kitai Y; Tabei Y; Nishimura K; Harada S
    Vaccine; 2010 Mar; 28(14):2664-70. PubMed ID: 20080072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody persistence after primary immunization with trivalent oral poliovirus vaccine.
    Krugman RD; Hardy GE; Sellers C; Parkman PD; Witte JJ; Meyer BC; Meyer HM
    Pediatrics; 1977 Jul; 60(1):80-2. PubMed ID: 195265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Persistence of latex-agglutination inhibiting and neutralizing antibodies against enterovirus in the healthy population (author's transl)].
    Schmidt WA; Brade H; Klein M; Krämer U
    Dtsch Med Wochenschr; 1975 Aug; 100(33):1663-6. PubMed ID: 169112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of antibodies in a population immunized with oral poliovaccine (OPV).
    Srámová H; Teplý V; Svandová E
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):212-9. PubMed ID: 231625
    [No Abstract]   [Full Text] [Related]  

  • 38. Polio antibody outfit of newborns and infants born after 20 years of mass vaccination with live poliovaccine.
    Koza J; Matyásová I; Danes L; Skovránek V; Havelková M
    J Hyg Epidemiol Microbiol Immunol; 1984; 28(1):25-32. PubMed ID: 6325534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of poliovirus neutralizing antibodies eight years after immunization with live, attenuated-virus vaccine.
    Rousseau WE; Noble GR; Tegtmeier GE; Jordan MC; Chin TD
    N Engl J Med; 1973 Dec; 289(25):1357-9. PubMed ID: 4356637
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibodies against Enteroviruses in different age groups.
    Bhatia VN; Gupta SP
    Indian J Med Res; 1968 Feb; 56(2):129-36. PubMed ID: 4297947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.